EGFR‐targeted liposomal nanohybrid cerasomes performed excellent theranostic functions and immune checkpoint inhibition in a mouse model of colorectal cancer (Figure 25).[156] The cerasome PD‐L1‐PCI‐Gd contains PS (porphyrin), T1 MRI contrast (Gd‐DSPE‐DOTA), NIR dye (DSPE‐IRDye800CW), and EGFR antibody (DSPE‐PEG‐cetuximab). Here, EGFR is linked to colorectal cancer.